Skip to content
Search
Elizabeth Glaser Pediatric AIDS Foundation logo
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
    • View All
  • Where We Work

    We are working toward an AIDS-free generation in over 20 countries.

    Featured Countries

    • Tanzania
    • Lesotho
    • Kenya
    • Where We Work

    Our Work

    We apply our expertise across the full spectrum of children’s health.

    Featured Work

    • Prevention of Mother-to-Child HIV Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
    • View All
  • Ideas & Impact
    • Ways to Give
    • Become a Partner
    • Join Team EGPAF
    • View All
Donate
Elizabeth Glaser Pediatric AIDS Foundation logo
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
    • View All
  • Where We Work

    We are working toward an AIDS-free generation in over 20 countries.

    Featured Countries

    • Tanzania
    • Lesotho
    • Kenya
    • Where We Work

    Our Work

    We apply our expertise across the full spectrum of children’s health.

    Featured Work

    • Prevention of Mother-to-Child HIV Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
    • View All
  • Ideas & Impact
    • Ways to Give
    • Become a Partner
    • Join Team EGPAF
    • View All
Donate
Search

Search Results

(
)

Filter by

Clear
Filter by health areas, people and populations, or solutions
Filter by EGPAF’s stories, research, resources or news

Journal Articles

Breastfeeding, Antiretroviral Therapy, HIV Transmission, and the HIV Reservoir

Published October 8, 2024

Recommendations on breastfeeding by persons living with HIV (PLWH) have shifted globally over time. Because the absolute risk for HIV transmission through breast milk in the absence of antiretroviral therapy (ART) is as high as 16% to 20%, recommendations for low-resource settings in the early 1990s initially emphasized replacement feeding…
View Resource

Topics:

Prevention of Mother-to-Child Transmission (PMTCT),

Research

Journal Articles

The Rollout of Paediatric Dolutegravir and Virological Outcomes Among Children Living with HIV in Mozambique

Published July 30, 2024

Background In 2022, Mozambique introduced Dolutegravir 10mg (pDTG), as part of paediatric antiretroviral therapy for children weighing < 20 kg. Understanding real-world challenges during national rollout can strengthen health systems in resource-limited settings. Objectives We described the transition rate to, and new initiation of, pDTG, viral load suppression (VLS)…
View Resource

Topics:

Pediatric HIV,

Research

Countries:

Mozambique

Journal Articles

Lessons from a Decade of Adult Vaccine Rollout in Low- and Middle-income Countries

Published June 27, 2024

Introduction The historical focus of vaccines on child health coupled with the advent of novel vaccines targeting adult populations necessitates exploring strategies for adult vaccine implementation. Areas covered This scoping review extracts insights from the past decade’s experiences introducing adult vaccines in low- and middle-income countries. Among 25 papers reviewed,…
View Resource

Topics:

Research

February 2022, BAIRRO 6, Locality Macia, District of Xai Xai, Gaza Province, Mozambique. Delivering the ARVs to a patient AND Health worker smiling next to a woman with child and husband

Journal Articles

Consistency of Multi-Month Antiretroviral Therapy Dispensing and Association with Viral Load Coverage Among Pediatric Clients Living with HIV in Mozambique

Published June 25, 2024

Abstract With the increase in uptake of multi-month antiretroviral therapy dispensing (MMD) for children, little is known about consistency of MMD receipt over time and its association with virological outcomes. This analysis aims to assess the uptake of 3-month MMD among children, consistent receipt of MMD after uptake, and clinical…
View Resource

Topics:

Differentiated Service Delivery,

Pediatric HIV,

Research

Countries:

Mozambique

Nurse Kettie Juma at work in a call center, socially distanced and wearing a face mask
Nurse Kettie Juma reaches out to fellow Malawians from the calling center in Lilongwe. She helps track spread of COVID-19 while also educating about prevention.

Journal Articles

Enhancing SARS-CoV- 2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022

Published May 16, 2024

Introduction Monitoring the SARS-CoV-2 pandemic in low-resource countries such as Malawi requires cost-effective surveillance strategies. This study explored the potential utility of phone-based syndromic surveillance in terms of its reach, monitoring trends in reported SARS-CoV-2-like/influenza-like symptoms (CLS/ILS), SARS-CoV-2 testing and mortality. Methods Mobile phone-based interviews were conducted between 1 July…
View Resource

Topics:

Global Health Security,

Research

Countries:

Malawi

Client receiving ARVs at Malawi clinic.

Journal Articles

Unlocking the Potential

Published April 30, 2024

Background The introduction of dolutegravir (DTG) in treating HIV has shown enhanced efficacy and tolerability. This study examined changes in weight gain and body mass index (BMI) at 6- and 12-months after post-initiating antiretroviral therapy (ART), comparing people living with HIV (PLHIV) on DTG-based regimens with those on non- DTG-based…
View Resource

Topics:

Research

Countries:

Malawi

Paolo Kenias is a volunteer in Malawi who connects his community to HIV services. Photo: Eric Bond/EGPAF 2017

Journal Articles

Early Effects of Scaling Up Dolutegravir‑Based ARV Regimens Among Children Living with HIV in Malawi

Published April 17, 2024

Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare…
View Resource

Topics:

HIV,

Pediatric HIV,

Research

Countries:

Malawi

Join Our Fight

With your help, we can and WILL achieve an AIDS-free generation. Stay up-to-date on the progress we’re making toward ending HIV/AIDS in children.
Opt-In
Elizabeth Glaser Pediatric AIDS Foundation

  • About
    • Elizabeth’s Story
    • Our Mission
    • Our Leadership
    • Our Partners
    • Our Ambassadors
  • Where We Work
  • What We Do
    • Prevention of Mother-to-Child Transmission
    • Pediatric HIV
    • Pediatric Tuberculosis (TB)
    • Adolescents, Youth, and HIV
    • Maternal, Newborn, and Child Health
    • Advanced HIV Disease
    • Digital Health
    • Public Policy and Advocacy
  • Ideas & Impact
  • Join Us
    • Give
    • Partner
    • Careers

For more than 35 years, EGPAF has carried forward Elizabeth Glaser’s fight. She taught us that specialized focus leads to breakthroughs. Her legacy is not just in the lives already saved, but in the vision of a world where no child is born with HIV.

Donate
  • Contracting Opportunities
  • Contact Us
  • Financial Information and Annual Reports
  • Ethics and Accountability
  • Privacy Policy

While the Elizabeth Glaser Pediatric AIDS Foundation makes effort to use photos which accurately depict the actions, topics, or populations referenced, unless specifically indicated, the photographs in this website do not imply program participation, health status, attitude, behavior, or action on the part of persons who appear therein.

1120 19th St NW, Suite 600, Washington DC 20036 | 202.296.9165 | Tax ID: #95-4191698

© 2026 Elizabeth Glaser Pediatric AIDS Foundation. All Rights Reserved.

  • Better Business Buerua Accredited Charity badge
  • Charity Navigator badge
  • Charity Watch A-Rated badge